撤回：MicroRNA-495 通过与人类表皮生长因子受体 2（ERBB2）相互作用，在胃癌中通过哺乳动物雷帕霉素靶蛋白（mTOR）信号通路赋予对化疗药物的敏感性。
Retracted: MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2).
机构信息
Department of Gastroenterology, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, Xinjiang, China.
出版信息
Med Sci Monit. 2024 Oct 1;30:e946684. doi: 10.12659/MSM.946684.
The Editors of Medical Science Monitor wish to inform you that the above manuscript has been retracted from publication due to concerns with the credibility and originality of the study, the manuscript content, and the Figure images. Reference: Na Li, Mei Han, Ning Zhou, Yong Tang, Xu-Shan Tang. MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2). Med Sci Monit, 2018; 24: CLR5990-5972. DOI: 10.12659/MSM.909458.
《医学科学监测》编辑谨此通知，由于对该研究的可信度和原创性、手稿内容以及图稿图像的担忧，上述稿件已被撤回出版。参考文献：Na Li, Mei Han, Ning Zhou, Yong Tang, Xu-Shan Tang. MicroRNA-495 通过与人类表皮生长因子受体 2（ERBB2）相互作用，赋予胃癌对化疗药物的敏感性，通过哺乳动物雷帕霉素靶蛋白（mTOR）信号通路。Med Sci Monit, 2018; 24: CLR5990-5972. DOI: 10.12659/MSM.909458.
Zotero 插件